← Leaderboards
Jeffrey P Jones
Washington State University
$7,106,337
Attributed
$8,405,661
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2005–19$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$8,405,661 · 7
By mechanism
R01$7,527,201 · 4
R21$548,426 · 2
S10$330,034 · 1
Top collaborators
- Kenneth Ray Korzekwa4 shared
- Swati Nagar4 shared
- Dmitri R Davydov2 shared
Most similar at Washington State University
Same institution · by research overlap
- Dmitri R Davydov$1,178,027
- Jennifer Schwartz$137,600
Others in their field
Top investigators on “Metabolism”
- David M Nathan · Massachusetts Institute Of Technology$157,845,616
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$144,157,234
- Judith S. Currier · University Of California Los Angeles$141,260,706
- John M Lachin · George Washington University$139,991,329
- Randall J Bateman · Washington University$124,168,384
- Carol Nesel · Westat$116,355,411
Research focus
MetabolismPharmaceutical PreparationsDrug InteractionsLifeCytochrome P450BaseDrug DevelopmentEnzymesInhibitor/AntagonistDrug MetabolismComputer SimulationDrug DesignMetabolicAffinityToxic EffectIn VitroGrantNovel TherapeuticsPublishingSeriesPublic Health RelevanceMediatingBinding (Molecular Function)Kinetics
Grant awards (28)
Improving prediction of drug interactions mediated by time-dependent inhibitors$402,680
R01 · FY2019 · GM
Understanding the Metabolic Impact of Aldehyde Oxidase on New Drug Design$392,397
R01 · FY2019 · GM · contact PI
Non-canonical Role of Ethanol-Inducible Cytochrome P450 Species in Alcohol-Drug Interactions and Alcohol-Related Disorders$181,688
R21 · FY2019 · AA · contact PI
Improving prediction of drug interactions mediated by time-dependent inhibitors$405,857
R01 · FY2018 · GM
Understanding the Metabolic Impact of Aldehyde Oxidase on New Drug Design$392,397
R01 · FY2018 · GM · contact PI
Non-canonical Role of Ethanol-Inducible Cytochrome P450 Species in Alcohol-Drug Interactions and Alcohol-Related Disorders$219,938
R21 · FY2018 · AA · contact PI
Improving prediction of drug interactions mediated by time-dependent inhibitors$410,642
R01 · FY2017 · GM
Understanding the Metabolic Impact of Aldehyde Oxidase on New Drug Design$391,773
R01 · FY2017 · GM · contact PI
Improving prediction of drug interactions mediated by time-dependent inhibitors$428,588
R01 · FY2016 · GM
Understanding the Metabolic Impact of Aldehyde Oxidase on New Drug Design$389,276
R01 · FY2016 · GM · contact PI
Understanding the Metabolic Impact of Aldehyde Oxidase on New Drug Design$258,236
R01 · FY2015 · GM · contact PI
Understanding the Metabolic Impact of Aldehyde Oxidase on New Drug Design$258,450
R01 · FY2014 · GM · contact PI
Understanding the Metabolic Impact of Aldehyde Oxidase on New Drug Design$249,602
R01 · FY2013 · GM · contact PI
Understanding the Metabolic Impact of Aldehyde Oxidase on New Drug Design$258,683
R01 · FY2012 · GM · contact PI
Predicting Rates and Regioselectivity in Cytochrome P450 Mediated Reactions$315,029
R01 · FY2011 · GM · contact PI
Predicting Rates and Regioselectivity in Cytochrome P450 Mediated Reactions$318,211
R01 · FY2010 · GM · contact PI
Predicting Rates and Regioselectivity in Cytochrome P450 Mediated Reactions$99,995
R01 · FY2010 · GM · contact PI
Predicting Rates and Regioselectivity in Cytochrome P450 Mediated Reactions$321,425
R01 · FY2009 · GM · contact PI
Predicting Rates and Regioselectivity in Cytochrome P450 Mediated Reactions$321,425
R01 · FY2008 · GM · contact PI
Cytochrome P450 Models for Risk Assessment$262,728
R01 · FY2007 · ES · contact PI
Cytochrome P450 Models for Risk Assessment$270,730
R01 · FY2006 · ES · contact PI
Cytochrome P450 Models for Risk Assessment$277,397
R01 · FY2005 · ES
Cytochrome P450 Models for Risk Assessment$277,542
R01 · FY2004 · ES
Cytochrome P450 Models for Risk Assessment$288,795
R01 · FY2003 · ES
Covalent Binding Methods for Early Drug Development$146,800
R21 · FY2003 · CA
TRIPLE QUADRUPOLE MASS SPECTROMETER$330,034
S10 · FY2001 · RR
CYTOCHROME P450 MODELS FOR RISK ASSESSMENT$271,598
R01 · FY2001 · ES
CYTOCHROME P450 MODELS FOR RISK ASSESSMENT$263,745
R01 · FY2000 · ES